DYNAMICURE
"DYNAMICURE" is a word mark owned by DynamiCure Biotechnology, LLC, filed at the USPTO on March 8, 2025. It has been allowed and covers classes 5 and 42.
- Status
- Allowed
- Since May 26, 2026
- Filed
- March 8, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99074324
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 2 classes
Who owns DYNAMICURE
The owner and representative on file with the office.
Owner
DynamiCure Biotechnology, LLC
Waltham, United States
Representative
Keith Toms
McCarter & English, LLP
What the mark covers
The products and services DYNAMICURE is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of oncological diseases and disorders; Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, autoimmune deficiency; Pharmaceutical preparations for the treatment of genetic disorders; Pharmaceutical preparations for the treatment of metabolic diseases; Pharmaceutical preparations for the treatment of neurodegenerative diseases; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of eye diseases; Pharmaceutical preparations for the treatment of cardiovascular diseases; Diagnostic biomarker reagents for medical purposes; Protein arrays for medical diagnosis purposes; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic preparations for medical purposes; Pharmaceutical preparations for the treatment of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all of the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases
Pharmaceutical research and development; Research and development in the field of biologics, namely, antibodies and peptides for the field of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of pharmaceuticals, biopharmaceuticals, and biotechnologies for the treatment of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, and cardiovascular diseases; Research and development in the field of biotechnology; Research and development in the field of laboratory testing, diagnostics, and pharmacogenetics for the treatment of cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Providing medical and scientific research information; Providing medical and scientific research information in the field of pharmaceutical research and development, biotechnology, and pharmacogenetics with respect to cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Consulting services in the field of pharmaceutical research and development; Consulting services in the field of biotechnology; Consulting services in the field of pharmacogenetics; Consulting services in the field of pharmaceutical research and development, biotechnology, and pharmacogenetics with respect to cancer, immunotherapies, autoimmune diseases, autoimmune disorders, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases eye diseases, and cardiovascular diseases; Research and development in the fields of oncological diseases and disorders, autoimmune diseases and disorders, autoimmune deficiency, genetic disorders, metabolic diseases, neurodegenerative diseases, kidney diseases, eye diseases, cardiovascular diseases, all the foregoing excluding treatments and diagnostics for neuromuscular disorders and orphan diseases
What has happened so far
Steps recorded by the USPTO, newest first.
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Application extension granted/receipt provided
- Application extension to response period - received
10 earlier steps on the official record.
About DYNAMICURE
Who owns the trademark "DYNAMICURE"?
The USPTO trademark "DYNAMICURE" (application 99074324) is owned by DynamiCure Biotechnology, LLC.
What is the status of "DYNAMICURE"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull DYNAMICURE and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a87-8f37-722b-b816-f291268ee219
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a87-8f37-722b-b816-f291268ee219",
"object": "trademark",
"mark_text": "DYNAMICURE",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99074324",
"filing_date": "2025-03-08",
"nice_classes": [
5,
42
],
"owners": [
{
"name": "DynamiCure Biotechnology, LLC",
"entity_id": null
}
]
}